Research using immunohistochemistry and enzyme-linked immunosorbent assays showed a poor prognosis in TLR4- and programmed cell death ligand 1 (PD-L1)-expressing NSCLC patients [29]. Here, CD274 is linked to non-small cell lung carcinoma.